Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial efficacy study of artesunate + sulfadoxine/pyrimethamine for Plasmodium falciparum and chloroquine for Plasmodium vivax in Afghanistan
ACTRN12622000944730Phase 4Completed
- Sponsor
- Ministry of Public Health
- Start
- Sep 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, sulfadoxine, pyrimethamine and chloroquine in malaria and Malaria (2 cohorts), sponsored by Ministry of Public Health. Primary endpoints: Treatment failure rate, Early treatment failure and 2 more. Started Sep 2016; status: completed.
02
Drugs
artesunatesulfadoxinepyrimethaminechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12622000944730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000944730.